Erlotinib Concurrent With Radiation Therapy in Non-small-cell Lung Cancer
NCT00973310
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Carcinoma, Non-Small Cell Lung
Interventions
OTHER:
Radiation Therapy and EGFR-TKI target therapy
Sponsor
Tianjin Medical University Cancer Institute and Hospital